Abstract
Helicobacter pylori NCTC 11637, which is nonviable at pH 3.0, became viable after addition of 10 mM urea owing to ammonia production by urease. In a buffer supplemented with urea, ecabet sodium decreased both the production of ammonia and the number of viable cells of H. pylori NCTC 11637 and changed the bacteria from the bacilliform to the horseshoe or doughnut shape in a concentration-dependent manner. In particular, ecabet sodium (2 and 4 mg/ml) decreased the number of viable cells below the control level. Benzohydroxamic acid, a urease inhibitor, also caused a decrease in ammonia production accompanied by a decrease in the number of viable cells and changed the morphological form at pH 3.0, but the number of viable cells was not lowered below the control level. In buffers at various pHs without urea, ecabet sodium showed a concentration-dependent bactericidal effect on H. pylori at pHs 4.0 and 5.0 but not at pHs 6.0 and 7.0 while benzohydroxamic acid caused only a slight decrease in the number of viable cells at pH 4.0. These results suggest that ecabet sodium has strong bactericidal activity in addition to its urease-inhibiting activity under acidic conditions.
Full Text
The Full Text of this article is available as a PDF (529.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell G. D., Powell K. U., Burridge S. M., Harrison G., Rameh B., Weil J., Gant P. W., Jones P. H., Trowell J. E. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med. 1993 Jun;86(6):375–382. [PubMed] [Google Scholar]
- Bode G., Malfertheiner P., Ströhle A., Mauch F., Nilius M., Ditschuneit H. Polymorphismus bei Helicobacter pylori--Schlüsselfunktion für Infektionsrezidive? Med Klin (Munich) 1992 Apr 15;87(4):179–184. [PubMed] [Google Scholar]
- Chiba N., Rao B. V., Rademaker J. W., Hunt R. H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992 Dec;87(12):1716–1727. [PubMed] [Google Scholar]
- Hazell S. L., Lee A., Brady L., Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis. 1986 Apr;153(4):658–663. doi: 10.1093/infdis/153.4.658. [DOI] [PubMed] [Google Scholar]
- Hazell S. L., Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 1986 Jul 5;2(8497):15–17. doi: 10.1016/s0140-6736(86)92561-4. [DOI] [PubMed] [Google Scholar]
- Ito Y., Fukushima T., Sugawara Y., Takaiti O., Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)- 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1- methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs. J Pharmacobiodyn. 1991 Sep;14(9):533–546. doi: 10.1248/bpb1978.14.533. [DOI] [PubMed] [Google Scholar]
- Ito Y., Nakamura S., Onoda Y., Sugawara Y., Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein. Jpn J Pharmacol. 1993 Jun;62(2):169–174. doi: 10.1254/jjp.62.169. [DOI] [PubMed] [Google Scholar]
- Ito Y., Onoda Y., Nakamura S., Tagawa K., Fukushima T., Sugawara Y., Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein. Jpn J Pharmacol. 1993 Jun;62(2):175–181. doi: 10.1254/jjp.62.175. [DOI] [PubMed] [Google Scholar]
- Ito Y., Sugawara Y., Takaiti O., Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a- octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1- phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). II. Distribution in the rat stomach. J Pharmacobiodyn. 1991 Sep;14(9):547–554. doi: 10.1248/bpb1978.14.547. [DOI] [PubMed] [Google Scholar]
- Itoh T., Yanagawa Y., Shingaki M., Takahashi M., Kai A., Ohashi M., Hamana G. Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates. Microbiol Immunol. 1987;31(7):603–614. doi: 10.1111/j.1348-0421.1987.tb03121.x. [DOI] [PubMed] [Google Scholar]
- Iwahi T., Satoh H., Nakao M., Iwasaki T., Yamazaki T., Kubo K., Tamura T., Imada A. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother. 1991 Mar;35(3):490–496. doi: 10.1128/aac.35.3.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marshall B. J., Barrett L. J., Prakash C., McCallum R. W., Guerrant R. L. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 1990 Sep;99(3):697–702. doi: 10.1016/0016-5085(90)90957-3. [DOI] [PubMed] [Google Scholar]
- Morgan D. R., Freedman R., Depew C. E., Kraft W. G. Growth of Campylobacter pylori in liquid media. J Clin Microbiol. 1987 Nov;25(11):2123–2125. doi: 10.1128/jcm.25.11.2123-2125.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NG L. K., Sherburne R., Taylor D. E., Stiles M. E. Morphological forms and viability of Campylobacter species studied by electron microscopy. J Bacteriol. 1985 Oct;164(1):338–343. doi: 10.1128/jb.164.1.338-343.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Onoda Y., Iwasaki H., Magaribuchi T., Tamaki H. Effects of the new anti-ulcer agent 12-sulfodehydroabietic acid monosodium salt on healing of acetic acid-induced gastric ulcers in rats. Arzneimittelforschung. 1991 May;41(5):546–548. [PubMed] [Google Scholar]
- Onoda Y., Magaribuchi T., Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats. Jpn J Pharmacol. 1989 Sep;51(1):65–73. doi: 10.1254/jjp.51.65. [DOI] [PubMed] [Google Scholar]
- Onoda Y., Takido M., Magaribuchi T., Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats. Jpn J Pharmacol. 1990 Apr;52(4):631–638. doi: 10.1254/jjp.52.631. [DOI] [PubMed] [Google Scholar]
- Tsujii M., Kawano S., Tsuji S., Fusamoto H., Kamada T., Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology. 1992 Jun;102(6):1881–1888. doi: 10.1016/0016-5085(92)90309-m. [DOI] [PubMed] [Google Scholar]
- Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
- Wada H., Kodato S., Kawamori M., Morikawa T., Nakai H., Takeda M., Saito S., Onoda Y., Tamaki H. Antiulcer activity of dehydroabietic acid derivatives. Chem Pharm Bull (Tokyo) 1985 Apr;33(4):1472–1487. doi: 10.1248/cpb.33.1472. [DOI] [PubMed] [Google Scholar]